Clinical Trial Update: Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis

View source ↗

Summary

A clinical trial update describing a study that measures endoscopic activity in ulcerative colitis patients treated with vedolizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Ulcerative Colitis | Status: UNKNOWN